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It has been 100 years since the first report of sickle haemoglobin (HbS). More than 50 years 
ago, it was suggested that the gene responsible for this disorder could reach high frequencies 
because of resistance conferred against malaria by the heterozygous carrier state. This 
traditional example of balancing selection is known as the ‘malaria hypothesis’. However, the 
geographical relationship between the transmission intensity of malaria and associated HbS 
burden has never been formally investigated on a global scale. Here, we use a comprehensive 
data assembly of HbS allele frequencies to generate the first evidence-based map of the 
worldwide distribution of the gene in a Bayesian geostatistical framework. We compare this 
map with the pre-intervention distribution of malaria endemicity, using a novel geostatistical 
area-mean comparison. We find geographical support for the malaria hypothesis globally; the 
relationship is relatively strong in Africa but cannot be resolved in the Americas or in Asia. 
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It has been a century since the first description of abnormally elon-gated red blood cells in an anaemic patient and the link with the clinical symptoms of what is now called sickle cell anaemia (SCA) 
was published1. Sickle haemoglobin (HbS), a structural variant of 
normal adult haemoglobin, results from a single amino acid substitu-
tion at position 6 of the beta globin molecule (β 6Glu→Val)2. When 
HbS is inherited from only one parent, the heterozygous child is 
usually an asymptomatic carrier2. When inherited from both parents, 
the homozygous child suffers from SCA. HbS is the most common 
pathological haemoglobin variant worldwide3. Without treatment, 
which is rarely available in low-income, high-burden countries4, 
the vast majority of children born with SCA die before the 
age of 5 years3. Natural selection should therefore have purged this 
mutation from human populations, but allele frequencies of HbS in 
excess of 15% have been observed5.
In 1949, it was suggested that the Darwinian paradox of high 
frequencies of genetic blood disorders could result from a selective 
advantage conferred by such disorders in protecting against Plas-
modium falciparum malaria infection in heterozygotes6. This bal-
ancing selection, commonly referred to as the ‘malaria hypothesis’, 
was originally suggested to explain the geographical correspond-
ence between the distribution of thalassaemia and malaria in the 
Mediterranean region, and was later confirmed7 in many locations 
including Sardinia8, Melanesia9,10 and Kenya11. At the same time, a 
similar relationship between HbS and malaria was independently 
discovered in Africa12,13. In vitro and in vivo studies have since added 
support for the protective role of HbS against malaria14,15.
Despite significant bibliographic assemblies of information on 
the distribution of HbS5,16, important limitations exist with previous 
mapping efforts17–19. These include (i) the inclusion of non-random 
population samples (such as those including patients with malaria 
or samples from related individuals) that could bias HbS allele fre-
quency estimates; (ii) poor discrimination between indigenous and 
recently migrated populations that could confound evidence of the 
relationship between HbS allele frequency and historical malaria 
endemicity; (iii) the lack of inclusion of HbS allele frequency local 
geographical heterogeneities; and (iv) limited documentation on the 
cartographic methodology used to generate maps, making them dif-
ficult to reproduce and evaluate objectively. More importantly, the 
geographical support for the malaria hypothesis has never advanced 
beyond visual comparison20–24.
In this study, we conduct a formal investigation of the geographi-
cal evidence in support of the malaria hypothesis at the global scale. 
In brief, we first updated previous data collections5,16 with online 
searches of the published literature, which we augmented using 
unpublished data from the Malaria Genomic Epidemiology Net-
work Consortium (MalariaGEN, http://www.malariagen.net)25, to 
create a comprehensive geodatabase of HbS allele frequency. These 
were reviewed using criteria devised to exclude sources of bias, such 
as those resulting from the inclusion of data from non-representa-
tive or non-indigenous populations. We then mapped these data 
using a Bayesian model-based geostatistical framework26–28. This 
enabled a comparison, for each pixel, between the modelled HbS 
allele frequency and the endemicity of malaria based on a unique 
categorical map reflecting its distribution before the era of interven-
tions for malaria control29. Finally, a geostatistical test for geographi-
cal association was devised, by computing the areal mean HbS allele 
frequency associated with each historical malaria endemicity class 
and calculating the probability that these mean values increased in 
each successive class.
Results
HbS allele frequency database and map. Searches of the literature 
identified 41,445 references (see Methods), 90% of which did not 
include data allowing allele frequency calculations. The application 
of additional inclusion criteria further restricted the total to 278 
informative references (see Supplementary References 64–342, 
cited in alphabetical order by surname), which have been used as 
inputs to our model. A total of 699 spatially unique data points were 
abstracted from these sources and entered into our georeferenced 
database with 74 additional surveys from MalariaGEN. Of these, 29 
(4%) were located in the Americas, 618 (80%) in Africa and Europe 
(mostly subSaharan Africa) and 126 (16%) in Asia (Fig. 1a and 
Supplementary Fig. S1).
Using our model (see Methods), we produced a continuous 
10 × 10 km resolution global raster grid of HbS allele frequency, 
with predictions drawn from the median of the posterior predictive 
distribution for each pixel (Fig. 1b), accompanied by a per-pixel esti-
mate of prediction uncertainty (Fig. 2). Empirical model perform-
ance was judged by comparing observed HbS allele frequencies with 
predicted values for a randomly removed subset of 10% of the data 
points, which revealed a mean error and a mean absolute error in HbS 
allele frequency predictions of  − 0.15 and 6.76%, respectively (see 
Methods). This global map of HbS allele frequencies should not be 
interpreted as showing the contemporary geographical distribution 
of this gene. It is the first global map of the distribution of the HbS 
gene, based on representative and indigenous population samples 
(see Methods).
Our HbS map (Fig. 1b) showed an HbS allele frequency of  > 0.5% 
to be present throughout most of the African continent, the Middle 
East and India and in localized areas in Mediterranean countries. 
The maximum predicted value of HbS allele frequency was 18.18% 
in northern Angola. A large contiguous area with frequencies above 
9% was observed stretching from southern Ghana to northern Zam-
bia. The map also indicated similar frequencies in an area extending 
from southern Senegal to northern Liberia, in localized patches in 
eastern Côte d’Ivoire, the eastern shores of Lake Victoria, southeast 
Tanzania and oases on the east coast of Saudi Arabia, as well as in 
the southern Chhattisgarh and southern Karnataka regions of India. 
Areas with frequencies above 6% were predicted in Madagascar, 
central Sudan, the west coast of Saudi Arabia, southeastern Turkey 
and in the Chalkidiki region of Greece. The many records of absence 
(Fig. 1a) and the very low HbS allele frequencies predicted by our 
model (Fig. 1b) also confirmed that HbS was largely absent from the 
Horn of Africa and from areas south of the Zambezi.
Spatial validation of the malaria hypothesis. To test the geograph-
ical association between HbS and malaria, we used the only avail-
able global map of preintervention malaria transmission intensity 
(endemicity; see Methods)29. On the basis of an assembly of histori-
cal malariometric information, this map categorized the world circa 
1900 into six classes of successively higher endemicity: malaria free, 
epidemic, hypoendemic, mesoendemic, hyperendemic and holoen-
demic (see Fig. 1c for endemicity class definitions)29,30.
The relationship between the predicted HbS allele frequencies 
and the level of malaria endemicity was summarized graphically 
in violin plots (Fig. 3), which illustrate the density distributions of 
predicted HbS allele frequencies within each endemic area. HbS 
was absent from epidemic areas, which were found only in north-
ern America and Eurasia. Globally, predicted HbS allele frequen-
cies were similar in malaria-free, hypoendemic and mesoendemic 
zones, but were substantially higher in hyperendemic and holo-
endemic areas (Fig. 3a). In Africa and Europe (Fig. 3b), an increase 
in HbS allele frequencies from hypoendemic through to holo-
endemic malaria zones was more pronounced. In Asia (Fig. 3c), 
no relation between predicted HbS allele frequencies and malaria 
endemicity was found. HbS was absent in the indigenous popula-
tions of the Americas.
Although the maps and violin plots provided a valuable insight 
into the covariation of HbS allele frequency and malaria endemic-
ity, our aim was to formally quantify the significance of any such 
relationship. Measurement of the difference between the areal mean 
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HbS allele frequency calculated within each endemicity area allowed 
us to quantify the statistical strength of such differences, taking into 
account the inherent uncertainty of the predicted HbS allele fre-
quencies (see Methods). Differences in areal means between ende-
micity regions were calculated for 100 unique realizations of the 
HbS allele frequency map generated by the Bayesian model (Fig. 4  
and Supplementary Fig. S2). When combined, these realizations 
produced predictive probability distributions for the difference in 
areal mean HbS allele frequency between each successive endemic-
ity class (see Table 1 and Methods).
These geostatistical measures provide the first quantitative 
evidence for a geographical link between the global distribution 
of HbS and malaria endemicity. At the global level, we found clear 
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Figure 1 | Global distribution of the sickle cell gene. (a) Distribution of the data points. Red dots represent the presence and blue dots the absence of the 
HbS gene. The regional subdivisions were informed by Weatherall and Clegg19, and are as follows: the Americas (light grey), Africa, including the western 
part of Saudi Arabia, and Europe (medium grey) and Asia (dark grey); (b) Raster map of HbS allele frequency (posterior median) generated by a Bayesian 
model-based geostatistical framework. The Jenks optimized classification method was used to define the classes45; (c) The historical map of malaria 
endemicity29 was digitized from its source using the method outlined in Hay et al.44 The classes are defined by parasite rates (PR2 − 10, the proportion of 
2- up to 10-year olds with the parasite in their peripheral blood): malaria free, PR2 − 10 = 0; epidemic, PR2 − 10 ≈ 0; hypoendemic, PR2 − 10 < 0.10; mesoendemic, 
PR2 − 10 ≥ 0.10 and  < 0.50; hyperendemic, PR2 − 10 ≥ 0.50 and  < 0.75; holoendemic, PR0 − 1 ≥ 0.75 (this class was measured in 0- up to 1-year olds)29,30.
High : 0.47
Low : 0.00
Figure 2 | Map of the uncertainty of the HbS allele frequency prediction. 
Interval between the 2.5 and 97.5% quantiles (95% probability) of the  
per-pixel predicted allele frequency using a continuous scale.
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differences between high endemicity classes (Fig. 4a), associated 
with a high probability of HbS allele frequency increases ( > 90%) 
from mesoendemic to hyperendemic and hyperendemic to holoen-
demic areas, as well as from epidemic to hypoendemic areas (Table 
1). In Africa, we observed a gradual increase from epidemic to 
holoendemic (Fig. 4b). High probabilities of increase were found 
between the same classes as in the global analysis, but also from 
hypoendemic to mesoendemic areas (87%). In Asia, differences 
between classes were much smaller (Fig. 4c) and the probabilities of 
increase were much lower between most classes, especially in areas 
of high endemicity.
Discussion
A strong geographical link between the highest HbS allele frequen-
cies and high malaria endemicity was observed at the global scale 
(Fig. 4a), but this observation is influenced primarily by the rela-
tionship found in Africa (Fig. 4b). The gradual increase in HbS 
allele frequencies from epidemic areas to holoendemic areas in 
Africa is consistent with the hypothesis that malaria protection by 
HbS involves the enhancement of not only innate but also acquired 
immunity to P. falciparum31. Interactions with haemoglobin C32,33 
might explain the lower HbS allele frequencies in West Africa24. 
Despite the presence of large malarious areas, HbS is absent in the 
Americas and in large parts of Asia2 (Fig. 1a). Therefore, no geo-
graphical confirmation of the malaria hypothesis could be identified 
in these regions. Although several haemoglobin variants have been 
identified in the Americas5, none of the malaria protective polymor-
phisms have been observed in the indigenous populations of this 
continent19. The combination of the low likelihood of an independ-
ent HbS mutation arising and a relatively low selection pressure 
(due to the absence of holoendemic areas, the more recent arrival of 
malaria, as well as the predominance of P. vivax) could contribute to 
the absence of HbS in that region. In Southeast Asia34, other malaria 
protective polymorphisms have been identified (haemoglobin E 
(HbE), the thalassaemias, glucose-6-phosphate dehydrogenase 
deficiency and Southeast Asian ovalocytosis) and levels of malaria 
endemicity were relatively high. It is suspected that HbE and South-
east Asian ovalocytosis in particular may have had epistatic inter-
actions35,36, altering the selection pressure for the HbS gene in that 
region37. The complex social structure and the predominance of 
P. vivax38 are also considered as likely to contribute to the unresolved 
geographical relationship in India. Ongoing work to create an 
open-access database for several malaria protective polymorphisms 
will allow more comprehensive distribution mapping and improve 
our understanding of their geographical interaction.
H
bS
 a
lle
le
 fr
eq
ue
nc
y 0.15
0.10
0.05
0.00
H
bS
 a
lle
le
 fr
eq
ue
nc
y 0.15
0.10
0.05
0.00
H
bS
 a
lle
le
 fr
eq
ue
nc
y 0.15
0.10
0.05
0.00
Malaria free
n = 1,847,900
Epidemic
n = 394,356
Hypoendemic
n = 594,008
Mesoendemic
n = 552,032
Hyperendemic
n = 339,100
Holoendemic
n = 105,744
Malaria free
n = 328,662
Epidemic
n = 64,252
Hypoendemic
n = 155,146
Mesoendemic
n = 143,998
Hyperendemic
n = 168,576
Holoendemic
n = 101,344
Malaria free
n = 704,970
Epidemic
n = 258,584
Hypoendemic
n = 320,756
Mesoendemic
n = 210,568
Hyperendemic
n = 132,802
Holoendemic
n = 4,400
Figure 3 | Comparison of the distribution of HbS and malaria. Violin plots 
of the predicted median HbS allele frequency for each pixel, within each 
malaria endemicity class, for the world (a), Africa and Europe (b) and Asia 
(c). The plot for the Americas is not shown as the predicted median was 
in the lowest histogram bin (between 0 and 0.5%) everywhere. The green 
areas match the colours used in the historical map of malaria endemicity 
(Fig. 1c) and show a smoothed approximation of the frequency distribution 
(a kernel density plot) of the predicted allele frequency within each 
endemicity class. The black central bar indicates the interquartile range 
and the white circles indicate the median values. The plots have been 
adjusted to an equal-area projection of the Earth.
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Figure 4 | Quantitative validation of the geographical support for the 
malaria hypothesis. Violin plots of the predictive distribution of the areal 
mean of HbS prevalence over each endemicity region, for the world (a), 
Africa and Europe (b) and Asia (c). The green areas match the colours 
used in the historical map of malaria endemicity (Fig. 1c) and show a 
smoothed approximation of the frequency distribution (a kernel density 
plot) of the predicted allele frequency within each endemicity class. The 
black central bar indicates the interquartile range and the white circles 
indicate the median values. The plots have been adjusted to an equal-area 
projection of the Earth.
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Substantial variations in HbS allele frequencies over short dis-
tances (up to 10% over  < 50 km) have been described in literature5, 
for example, in relation to altitude, rainfall or Anopheles survival39, 
which underlie variations in selection40. Such spatial heterogene-
ity was observed in the geodatabase. The combination of a detailed 
georeferencing process, the use of a geostatistical model able to 
incorporate the multiple scales of variation within the data and a 
semicontinuous gradient of HbS allele frequencies allowed us to 
describe the global distribution and the high geographical variabil-
ity of this gene more rigorously than achieved in previous maps17–19. 
The uncertainty measure (see Fig. 2) provides an important esti-
mate of the limitations associated with a retrospective data set, 
and can highlight areas prone to small population samples and/or 
areas lacking observations (for example, New Zealand).
Among the factors that might contribute to the heterogeneity 
observed in the HbS allele frequency in hyperendemic areas in Africa 
(Fig. 3b), we identified (i) a component of geographical sampling 
error from an ‘opportunistic sample’ of surveys that we were able to 
source from literature; (ii) the kinetics of the spread of the HbS gene, 
which leads to an exponential increase in areas in which a selective 
pressure appears, but to a much slower decrease in areas in which the 
selective pressure disappears41; (iii) long-term (sociological or physi-
cal) isolation of local populations, which could result in pockets of 
lower HbS allele frequencies observed on the map (Fig. 1b).
One hundred years after the first description of SCA, we used a 
comprehensive search combined with a rigorous selection of survey 
data and modern mapping methods to create a new, evidence-based 
map of the worldwide distribution of HbS allele frequency and to 
quantify the uncertainty in these mapped predictions. Using a novel 
geostatistical approach that accounts for this uncertainty, we have 
compared this new map with a historical map of the global ende-
micity of malaria. We provide the first geographical and quantitative 
confirmation of the malaria hypothesis at the global scale.
Methods
Creating a global database of sickle cell allele frequencies. A schematic  
overview of the methods used is provided as Figure 5. To identify publications 
with HbS allele frequency data, a comprehensive electronic data search was 
undertaken using PubMed (http://www.pubmed.gov), ISI Web of Knowledge 
(http://isiwebofknowledge.com) and Scopus (http://www.scopus.com), using 
the following keyword string: ‘sickle cell’ or ‘haemoglobin S’ or ‘hemoglobin S’ 
or ‘Hb S’. Initial searches were conducted on 12 December 2007 and updated on 
20 October 2009. A total of 18,336 (in Text terms), 28,908 (in Title/Keywords/
Abstract) and 22,732 (in Article Title/Abstract/Keywords) references were found 
in the three respective databases and exported using bibliographic management 
software. The 2,220 references from Livingstone’s extensive but out-of-date data-
base on frequencies of haemoglobin variants5 were then added. Duplicates were 
removed manually. Titles and abstracts, when available, were then reviewed to 
identify references that met the following selection criteria: first, that the popula-
tion sample was representative of an indigenous population. When multiple 
surveys included similar subsets of population samples, only the larger one was 
included, provided that all the other inclusion criteria were fulfilled. When multi-
ple surveys were totally independent, each survey was included in the model. Few 
studies corresponded to a purely random or universal sample of the population 
studied; therefore, all unselected samples were included. Studies of patients, with 
sickle cell or any other condition, were excluded. We considered population sur-
veyed as indigenous, if no information was available from the author to suspect 
that the population did not evolve locally in relation to the historical prevalence 
of malaria. Non-native populations surveyed in the Americas or Western Europe, 
for example, were therefore excluded. Surveys explicitly surveying a specific eth-
nic group, not representative of the overall population at the sampling site, were 
excluded. Although ethnic group information was recorded when available, it was 
not used in the model because of (i) inconsistency of information provided by the 
sources and ethnic group definitions used and (ii) contradicting local results in 
the relationship between ethnicity and HbS allele frequency. Second, details were 
needed on the number of individuals sampled and on the AA and AS genotypes 
identified. Sources reporting an allele frequency but no sample size were thus 
excluded. Because of (i) the complexity of the multiple compound status when 
HbS is inherited with another structural variant, haemoglobin C or HbE, or with 
a thalassaemia, α- or β-, (ii) the small number of individuals involved (apart from 
in the Mediterranean countries) and (iii) the inconsistencies in the identification 
of such cases, these individuals were not included in the calculations of the HbS 
allele frequency. Third, the survey description needed to be spatially explicit so 
that it could be georeferenced (see below). Using these strict criteria for inclusion, 
we identified 278 references with data allowing us to calculate an allele frequency 
for HbS (see Supplementary References 64–342). Data on absences of HbS in 
populations, such as native Americans, were also included in this study, as they 
usually constituted isolated data points that are very informative for a global 
predictive model. Finally, genotype data collected by the Malaria Genomic Epide-
miology Network Consortium (MalariaGEN, http://www.malariagen.net)25 were 
added to the database as they represent a significant source of standardized data 
from malaria-endemic countries.
Table 1 | Probabilities of an increase in the areal mean for each pair of consecutive malaria endemicity classes.
Malaria free– 
epidemic
Epidemic–
hypoendemic
Hypoendemic–
mesoendemic
Mesoendemic–
hyperendemic
Hyperendemic–
holoendemic
World 0.0366 0.9729 0.6570 0.9996 0.9998
The Americas 0.1312 0.5170 0.4245 0.4202 NA
Africa 0.0030 0.9939 0.8744 0.9964 0.9422
Asia 0.0966 0.9210 0.7646 0.6047 0.0041
Abbreviation: NA, not applicable.
The Monte Carlo s.e. of the estimate were all lesser than 0.001.
Model input (n = 773)
HbS strict inclusion criteria
Predicted distribution of
HbS allele frequency in local populations
(at 10 km × 10 km grid locations)
AA AS LAT
Nested Bayesian geostatistical model
LON
Global geodatabase of HbS data
(1950–2009)
Geographical validation of themalaria hypothesis
Online searches (1950–2009)
PubMed
(n = 18,336)
ISI Web of
Knowledge
(n = 28,908)
Scopus
(n = 22,732)
Without duplicates
(n = 41,445)
Lysenko malaria
endemicity map
Figure 5 | Schematic overview of the data collection and mapping 
processes. Blue diamonds describe input data. Orange boxes denote 
models and experimental procedures. Green rods indicate output data.
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Georeferencing. We used the georeferencing procedure developed by the Malaria 
Atlas Project (MAP, http://www.map.ox.ac.uk), which is described in Guerra  
et al.42 Geographic coordinates could be found for 459 population samples, located 
as points ( < 10 km2). The centroid of polygons was used for the 314 population 
samples that could be georeferenced to district level (admin2 unit) or to a smaller 
area clearly defined by the author (for example, detailed map of the study area). 
Studies that could only be located to province (admin1 unit) or country (admin0 
unit) level were excluded.
Creating a continuous map of sickle cell allele frequency. The number of 
individuals with AA and AS genotypes was used to calculate allele frequencies. 
Individuals described as sicklers were all considered as heterozygotes (AS). All 
SS individuals were assumed to die shortly after birth, meaning we discarded the 
few records of SS individuals in the database. Preliminary analysis (not shown) 
indicated that the resulting likelihood functions at points with SS individuals were 
very similar to those obtained using standard Hardy–Weinberg assumptions. Even 
today, medical services for improving the survival of sickle cell patients (SS) are 
rarely available outside economically developed countries, where the burden of 
sickle cell is greatest, and would have been more rudimentary before the 1990s, 
when two-thirds of the surveys were conducted. It seems reasonable therefore to 
assume that the few surviving HbS homozygous individuals were unlikely to sub-
stantively affect HbS allele frequency estimates. When only an allele frequency and 
the sample size were given, the number of AA and AS individuals was calculated 
by assuming that the genotypes of newborns were in Hardy–Weinberg proportions 
but that all SS individuals had died by the time of the surveys. The sample size was 
recalculated as the sum of AA and AS individuals. Information on age could not 
be taken into account as it was provided in only 45% of the sources. Among these, 
samples were taken from cord blood/neonates (n = 23,152), children (n = 26,205), 
adults (n = 219,966) and mixed groups (n = 78,111). The inputs to the geostatisti-
cal model were the coordinates of the population studied (lat/long in decimal 
degrees, WGS84) and the number of AS (positive) and AA (negative) individuals. A 
Bayesian geostatistical model involving a two-part nested covariance function was 
fitted to these data and 500,000 Markov chain Monte-Carlo iterations43 were used 
to predict HbS allele frequencies at unsampled locations and generate continuous 
maps. Because of the high heterogeneity of allele frequencies in areas in which HbS 
is present, the small set of HbS absences, for example, in the Americas, was not suf-
ficient to rule out the possibility that HbS allele frequency could be relatively high in 
some places. For that reason, the posterior predictive distribution of allele frequen-
cies in the Americas tended to have a long right-hand tail, and point estimates of 
allele frequency tended to be surprisingly high. A thinned 10% sample of the data 
was used to map various summary statistics of the posterior predictive distribution 
of HbS allele frequency at unsampled locations. To validate the predictions of the 
model, the analysis was repeated with 90% of the data set, and predictions at the 
locations of the held-out data points were evaluated. See Supplementary Methods 
for details on the statistical analysis.
Comparing with a precontrol map of malaria endemicity. In the late 1960s, a 
team of Russian researchers conducted a synthesis of historical records, documents 
and maps of several malariometric indices used to record malaria endemicity29. 
Combined with expert opinion and data on temperature and rainfall, this review 
allowed them to create a unique global map of the precontrol distribution of 
malaria, at the peak of its hypothesized distribution44. We chose to use this malaria 
map for reasons detailed in Supplementary Methods. Similar to traditional box 
plots, violin plots allow the comparison of a semicontinuous variable (HbS allele 
frequency) with a categorical variable (malaria endemicity class). In addition, they 
show the density distribution of the observations or predictions. The analysis of the 
violin plots of the allele frequencies within each endemicity class is supported by a 
visual interpretation of the plots. To quantify the differences between malaria en-
demicity classes, we calculated the probability of finding a higher allele frequency 
in one class than in the class just below on the basis of their geographical pattern. 
The posterior predictive distribution of the areal mean of the HbS allele frequency 
over each endemicity class was plotted by region (Fig. 4). The posterior probability 
of an increase in the areal mean HbS allele frequency for each pair of consecutive 
malaria endemicity classes, along with the Monte-Carlo standard errors associated 
with those estimates, was then calculated. Probabilities of zero and one indicate 
that the HbS allele frequency in an endemicity class is certainly lower or higher, 
respectively, than in the adjacent class. A probability of 0.5 corresponds to an equal 
chance of an increase or decrease. Further details are provided in Supplementary 
Methods. These comparisons have been made globally and regionally for Europe 
and Africa, and for Asia. The separation into these two regions was based on the 
distinct haplotypes occurring east and west of Saudi Arabia (see Fig. 1a)19,37. 
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